☰

Gabor Szeplaki, Dr. - Publications

Affiliations: 
2008 Semmelweis Egyetem, Hungary 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Herczeg S, Galvin J, Keaney JJ, Keelan E, Byrne R, Howard C, Geller L, Szeplaki G. The Value of Voltage Histogram Analysis Derived Right Atrial Scar Burden in the Prediction of Left Atrial Scar Burden. Cardiology Research and Practice. 2020: 3981684. PMID 32855820 DOI: 10.1155/2020/3981684  0.306
2020 Tokodi M, Schwertner WR, Kovács A, Tősér Z, Staub L, Sárkány A, Lakatos BK, Behon A, Boros AM, Perge P, Kutyifa V, Széplaki G, Gellér L, Merkely B, Kosztin A. Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score. European Heart Journal. PMID 31923316 DOI: 10.1093/Eurheartj/Ehz902  0.304
2019 Boles U, Refila B, Gul EE, Szeplaki G, Keaney J, Galvin J, Keelan E. Ventricular Tachycardia Storm After Standard Radiofrequency Pulmonary Vein Isolation. The American Journal of Case Reports. 20: 1536-1539. PMID 31628298 DOI: 10.12659/Ajcr.918432  0.331
2019 Weberndörfer V, Beinart R, Ricciardi D, Ector J, Mahfoud M, Szeplaki G, Hemels M. Sex differences in rate and rhythm control for atrial fibrillation. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 30843036 DOI: 10.1093/Europace/Euy295  0.318
2019 Szegedi N, Széplaki G, Herczeg S, Tahin T, Salló Z, Nagy VK, Osztheimer I, Özcan EE, Merkely B, Gellér L. Repeat procedure is a new independent predictor of complications of atrial fibrillation ablation. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 30689857 DOI: 10.1093/Europace/Euy326  0.307
2018 Szegedi N, Szeplaki G, Tahin T, Herczeg S, Nagy KV, Oszheimer I, Ozcan EE, Merkely B, Geller L. P901Prospective evaluation of incidence and predictors of complications of atrial fibrillation ablation in a high-volume electrophysiology center Ep Europace. 20: i172-i173. DOI: 10.1093/Europace/Euy015.502  0.305
2018 Nagy KV, Szegedi N, Széplaki G, Tahin T, Osztheimer I, Herczeg S, Salló Z, Merkely B, Geller L. LONG-TERM MORTALITY PREDICTORS IN ISCHAEMIC OR NON-ISCHAEMIC PATIENTS UNDERGOING VT ABLATION Journal of the American College of Cardiology. 71: A476. DOI: 10.1016/S0735-1097(18)31017-9  0.32
2018 Bettenbuch T, Srej M, Széplaki G, Szegedi N, Nagy K, Merkely B, Gellér L. PO370 The Success of Catheter Ablation Therapy in Patients With Atrial Fibrillation in a High Volume Center Global Heart. 13: 457. DOI: 10.1016/J.Gheart.2018.09.287  0.339
2017 Jefferies J, Walsh K, McGorrian C, Keelan E, Szeplaki G, Galvin J, Keany J. 51 Does degree of low amplitude atrial voltage correlate with poor left atrial function in atrial fibrillation Heart. DOI: 10.1136/Heartjnl-2017-Ics17.51  0.311
2017 Nagy K, Szegedi N, Szeplaki G, Tahin T, Osztheimer I, Herczeg S, Sallo Z, Merkely B, Geller L. P806Predictors of long-term mortality in patients undergoing ischaemic or non-ischaemic ventricular tachycardia ablation European Heart Journal. 38. DOI: 10.1093/Eurheartj/Ehx501.P806  0.3
2017 Perge P, Boros A, Zima E, Molnar L, Tahin T, Geller L, Prohaszka Z, Merkely B, Szeplaki G. P1559Hyperuricemia predicts mortality and the lack of reverse remodeling in CRT patients Ep Europace. 19: iii327-iii327. DOI: 10.1093/Ehjci/Eux158.185  0.3
2016 Boros AM, Perge P, Jenei Z, Karády J, Zima E, Molnár L, Becker D, Gellér L, Prohászka Z, Merkely B, Széplaki G. Measurement of the Red Blood Cell Distribution Width Improves the Risk Prediction in Cardiac Resynchronization Therapy. Disease Markers. 2016: 7304538. PMID 26903690 DOI: 10.1155/2016/7304538  0.332
2016 Szegedi N, Gellér L, Tahin T, Merkely B, Széplaki G. [Successful direct thrombin inhibitor treatment of a left atrial appendage thrombus developed under rivaroxaban therapy]. Orvosi Hetilap. 157: 154-6. PMID 26772828 DOI: 10.1556/650.2016.30350  0.339
2016 Travers J, Keelan E, Keaney J, Szeplaki G, Valentine J, Hayam G, Galvin J. 96-22: Comparison of a novel tool for automatic measurement of left atrial scar burden with visual estimation in patients undergoing ablation of atrial fibrillation Europace. 18. DOI: 10.1093/Europace/18.Suppl_1.I65A  0.312
2015 Nagy VK, Széplaki G, Apor A, Kutyifa V, Kovács A, Kosztin A, Becker D, Boros AM, Gellér L, Merkely B. Role of Right Ventricular Global Longitudinal Strain in Predicting Early and Long-Term Mortality in Cardiac Resynchronization Therapy Patients. Plos One. 10: e0143907. PMID 26700308 DOI: 10.1371/Journal.Pone.0143907  0.329
2015 Kosztin A, Kutyifa V, Nagy VK, Geller L, Zima E, Molnar L, Szilagyi S, Ozcan EE, Szeplaki G, Merkely B. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 26116830 DOI: 10.1093/Europace/Euv117  0.315
2015 Széplaki G, Szegedi N, Tahin T, Merkely B, Gellér L. Successful Catheter Ablation of Right Atrial Tachycardia After Bilateral Lung Transplantation. Transplantation. 99: e115-6. PMID 25929605 DOI: 10.1097/Tp.0000000000000759  0.311
2015 Szegedi N, Szeplaki G, Merkely B, Geller L. Successful emergency ablation of ventricular tachycardia in the early postoperative period after left ventricular assist device implantation. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. 104: 450-2. PMID 25604187 DOI: 10.1007/S00392-015-0813-8  0.323
2014 Széplaki G, Özcan EE, Osztheimer I, Tahin T, Merkely B, Gellér L. Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with Brugada syndrome refusing implantable cardioverter defibrillator therapy. The Canadian Journal of Cardiology. 30: 1249.e9-1249.e11. PMID 25262866 DOI: 10.1016/J.Cjca.2014.05.019  0.328
2014 Özcan EE, Szeplaki G, Tahin T, Osztheimer I, Szilagyi S, Apor A, Horvath PM, Vago H, Merkely B, Geller L. Impact of respiration gating on image integration guided atrial fibrillation ablation. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. 103: 727-31. PMID 24803131 DOI: 10.1007/S00392-014-0707-1  0.312
2014 Széplaki G, Özcan EE, Merkely B, Gellér L. PM019 Successful ablation of the arrhythmogenic substrate in the epicardial right ventricular outflow tract in a patient with Brugada syndrome refusing implantable cardioverter defibrillator therapy Global Heart. 9: e65. DOI: 10.1016/J.Gheart.2014.03.1439  0.314
2013 Özcan EE, Osztheimer I, Széplaki G, Merkely B, Gellér L. Successful ablation of atrioventricular nodal re-entrant tachycardia in a patient with interruption of inferior vena cava and azygos continuation. The Canadian Journal of Cardiology. 29: 1741.e9-11. PMID 24404612 DOI: 10.1016/J.Cjca.2013.08.014  0.331
2013 Ozcan EE, Szeplaki G, Merkely B, Geller L. Non-reentrant atrioventricular nodal tachycardia. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. 102: 383-6. PMID 23361366 DOI: 10.1007/S00392-013-0537-6  0.317
2013 Jenei ZM, Széplaki G, Merkely B, Karádi I, Zima E, Prohászka Z. Persistently elevated extracellular HSP70 (HSPA1A) level as an independent prognostic marker in post-cardiac-arrest patients. Cell Stress & Chaperones. 18: 447-54. PMID 23321917 DOI: 10.1007/S12192-012-0399-2  0.348
2013 Geller L, Molnar L, Tahin T, Szilagyi SZ, Zima E, Szeplaki G, Osztheimer I, Solymossy K, Evren Ozcan E, Merkely B. Transseptal endocardial left ventricular lead implantation is safe and effective alternative of conventional resynchronisation therapy European Heart Journal. 34: P3193-P3193. DOI: 10.1093/Eurheartj/Eht309.P3193  0.304
2013 Kutyifa V, Zima E, Szilagyi SZ, Roka A, Szucs G, Kosztin A, Molnar L, Szeplaki G, Geller L, Merkely B. Intraoperative right to left ventricular interlead delay predicts outcome in CRT recipients European Heart Journal. 34: 52-52. DOI: 10.1093/Eurheartj/Eht307.52  0.317
2011 Végh EM, Széplaki G, Szilágyi S, Osztheimer I, Tahin T, Merkely B, Gellér L. [Electroanatomical mapping and radiofrequency ablation of tachycardia originating in pulmonary vein in an adult patient]. Orvosi Hetilap. 152: 1374-8. PMID 21835744 DOI: 10.1556/Oh.2011.29194  0.337
2010 Kelemen Z, Moldovan D, Mihály E, Visy B, Széplaki G, Csuka D, Füst G, Farkas H, Varga L. Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema. Clinical Immunology (Orlando, Fla.). 134: 354-8. PMID 19945350 DOI: 10.1016/J.Clim.2009.11.002  0.342
2008 Varga L, Széplaki G, Laki J, Kocsis A, Kristóf K, Gál P, Bajtay Z, Wieslander J, Daha MR, Garred P, Madsen HO, Füst G, Farkas H. Depressed activation of the lectin pathway of complement in hereditary angioedema. Clinical and Experimental Immunology. 153: 68-74. PMID 18460017 DOI: 10.1111/J.1365-2249.2008.03671.X  0.727
2008 Széplaki G, Varga L, Szépvölgyi A, Simon K, Blaskó B, Nagy E, Karádi I, Füst G, Farkas H. Acquired angioedema associated with primary antiphospholipid syndrome in a patient with antithrombin III deficiency. International Archives of Allergy and Immunology. 146: 164-8. PMID 18204284 DOI: 10.1159/000113521  0.362
2008 Szegedi R, Széplaki G, Varga L, Prohászka Z, Széplaki Z, Karádi I, Füst G, Farkas H. Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients. Atherosclerosis. 198: 184-91. PMID 17977544 DOI: 10.1016/J.Atherosclerosis.2007.09.025  0.311
2007 Széplaki G, Varga L, Laki J, Dósa E, Rugonfalvi-Kiss S, Madsen HO, Prohászka Z, Kocsis A, Gál P, Szabó A, Acsády G, Karádi I, Selmeci L, Garred P, Füst G, et al. Low c1-inhibitor levels predict early restenosis after eversion carotid endarterectomy. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 2756-62. PMID 17916775 DOI: 10.1161/Atvbaha.107.146860  0.732
2007 Farkas H, Jakab L, Temesszentandrási G, Visy B, Harmat G, Füst G, Széplaki G, Fekete B, Karádi I, Varga L. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. The Journal of Allergy and Clinical Immunology. 120: 941-7. PMID 17761272 DOI: 10.1016/J.Jaci.2007.06.026  0.328
2007 Blaskó B, Széplaki G, Varga L, Ronai Z, Prohászka Z, Sasvari-Szekely M, Visy B, Farkas H, Füst G. Relationship between copy number of genes (C4A, C4B) encoding the fourth component of complement and the clinical course of hereditary angioedema (HAE). Molecular Immunology. 44: 2667-74. PMID 17229465 DOI: 10.1016/J.Molimm.2006.12.007  0.308
2007 Varga L, Széplaki G, Visy B, Füst G, Harmat G, Miklós K, Németh J, Cervenak L, Karádi I, Farkas H. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients. Molecular Immunology. 44: 1454-60. PMID 16750855 DOI: 10.1016/J.Molimm.2006.04.020  0.381
2007 Széplaki G, Szegedi R, Széplaki Z, Prohászka Z, Varga L, Romics L, Karádi I, Füst G, Farkas H. The impact of hereditary C1-inhibitor deficiency on the development of atherosclerosis World Allergy Organization Journal. DOI: 10.1097/01.Wox.0000301784.19727.Ff  0.31
2007 Prohászka Z, Széplaki G, Varga L, Laki J, Dósa E, Madsen HO, Szabó A, Acsády GY, Selmeci L, Garred P, Füst G, Entz L. Low C1-inhibitor levels predict early restenosis in patients who underwent eversion type carotid endarterectomy Molecular Immunology. 44: 230. DOI: 10.1016/J.Molimm.2006.07.194  0.739
2007 Farkas H, Temesszentandrási G, Visy B, Harmat G, Varga L, Füst G, Széplaki G, Karádi I, Fekete B, Jakab L. Over 10 Years Of Experience With The Use Of C1-inhibitor Concentrate In Hereditary Angioedema, In Retrospect The Journal of Allergy and Clinical Immunology. 119. DOI: 10.1016/J.Jaci.2006.12.588  0.59
2006 Széplaki G, Varga L, Laki J, Dósa E, Madsen HO, Prohászka Z, Szabó A, Acsády G, Selmeci L, Garred P, Füst G, Entz L. Elevated complement C3 is associated with early restenosis after eversion carotid endarterectomy. Thrombosis and Haemostasis. 96: 529-34. PMID 17003933 DOI: 10.1160/Th06-05-0263  0.734
2006 Harcos P, Laki J, Kiszel P, Széplaki Z, Szolnoki Z, Kovács M, Melegh B, Széplaki G, Füst G, Blaskó B. Decreased frequency of the TNF2 allele of TNF-alpha -308 promoter polymorphism is associated with lacunar infarction. Cytokine. 33: 100-5. PMID 16473522 DOI: 10.1016/J.Cyto.2005.12.006  0.676
2005 Széplaki G, Varga L, Valentin S, Kleiber M, Karádi I, Romics L, Füst G, Farkas H. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. The Journal of Allergy and Clinical Immunology. 115: 864-9. PMID 15806011 DOI: 10.1016/J.Jaci.2004.12.1130  0.309
2004 Széplaki G, Prohászka Z, Duba J, Rugonfalvi-Kiss S, Karádi I, Kókai M, Kramer J, Füst G, Kleiber M, Romics L, Varga L. Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis. 177: 383-9. PMID 15530914 DOI: 10.1016/J.Atherosclerosis.2004.07.022  0.379
Show low-probability matches.